[ad_1]
Former CMO is poised to agree new role with HSE’s National Cancer Control Programme
Dr Holohan will be working specifically on cancer prevention and treatment, despite his role in the CervicalCheck scandal being the source of controversy.
The salary with the new post ranges up to €257,000 – well above what he was paid as CMO.
Dr Holohan’s official biography says he “advises a number of leading companies in the healthcare sector”.
He is chair of the Enfer Medical Advisory Board, the country’s leading clinical laboratory carrying out clinical diagnostic results. Among its services is testing for bowel cancer, the third most common cancer worldwide and the second largest cause of death related to cancer.
Enfer Medical did not respond to queries about Dr Holohan’s status.
Dr Holohan is now understood to have been the successful candidate in an open competition for a new post of consultant in public health medicine in the HSE’s National Cancer Control Programme (NCCP).
The HSE said the process for filling the post is “still ongoing” and declined to comment further. But a senior health service official did point to the HSE Codes of Standards and Behaviour.
“Employees may not engage in outside business or activity which would in any way conflict with the interests of their departments/offices,” the document says. “Employees shall not accept an appointment, or particular consultancy project, where the employees concerned believe that the nature and terms of such appointment could lead to a conflict of interest or the perception of such, without first obtaining the approval of the human resources department of HSE.”
Dr Holohan is also a board member of the Irish Hospice Foundation and Adjunct Full Professor of Public Health at UCD. But charity and academic work is unlikely to interfere with his new role.
The doctor, who shot to fame during the Covid-19 pandemic, is poised to become a consultant in public health medicine. He was previously at the centre of a scandal over a botched plan to appoint him to a university post.
The NCCP works with health service providers around the country to prevent and treat cancer, and increase survival and quality of life for those who develop cancer.
The offer of the job has not yet been made and he has not yet been appointed, but Dr Holohan has been informed he is the preferred candidate for the role.
Dr Holohan’s previous salary as CMO was more than €187,000. He will now be signing up the new medical consultants’ contract salary, ranging from €214,000 to €257,000.
Since stepping down as CMO, Dr Holohan has written a memoir.
His wife, Dr Emer Holohan, died in 2021 after suffering for the previous decade from a rare of form of blood cancer.
The post Dr Holohan applied for is attached to the NCCP and was recruited through a Public Appointments Service process.
But Dr Holohan’s role in the CervicalCheck scandal has provoked controversy. He advised the Government against a review of the screening programme.
[ad_2]
Source link
